Analyst questions the bigger picture for GILD, including risks and visibility challenges wavering in 2018.
Here’s Why Facebook and Amazon Are Long-Term Winners of the Wall Street Horse Race
Trade Desk Inc (NASDAQ:TTD) stock is ticking upward today, after the digital ad firm delivered another beat and raise quarter, driven by sustained …
In a research report issued Friday, Jefferies analyst Matthew Andrews assumed coverage on shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), with a Buy rating and a $7.00 price …
Jefferies analyst Brian Fitzgerald is out with a confident research note evaluating Snap Inc (NYSE:SNAP) today, specifically commending the popular Snapchat app parent company’s …
Analysts see an interesting path ahead for Gilead Sciences, Inc. (NASDAQ:GILD), between exciting collaborative possibilities and its pipeline catalysts that have brought bullish …
Jefferies analyst Brian Fitzgerald is joining the earnings conversation with mixed takes on Facebook Inc (NASDAQ:FB) and Shutterfly, Inc. (NASDAQ:SFLY).
Previewing fourth-quarter earnings, Jefferies analyst Brian Fitzgerald is setting confident expectations on the following large-cap internet stocks in his coverage: Facebook Inc (NASDAQ:FB), Amazon.com, …
Jefferies analyst Brian Fitzgerald has reiterated his Buy rating for Alphabet Inc (NASDAQ:GOOGL) following yesterday’s reveal that the tech giant and Honda are in …
Valeant Pharmaceuticals Intl Inc Wells Fargo analyst David Maris weighs in on shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), as the drug maker focuses …